News

Call for Proposals: 2021 Fall HSCI Collaborative Seed Grants

June 21, 2021

CALL FOR PROPOSALS

FALL 2021 HSCI COLLABORATIVE SEED GRANTS

 

AWARD AMOUNT
$100,000 per project per year for up to two years
POSTED DATE
Monday, June 21, 2021
DEADLINE FOR APPLICATION
Friday, September 17, 2021
ANTICIPATED AWARD DATE
Monday, November 1, 2021

 

The Harvard Stem Cell Institute (HSCI) invites applications for seed grant funding for its Fall 2021 cycle.

The purpose of this program is to provide funding for innovative projects in the field of stem cell and regenerative biology that are a collaboration between two labs. HSCI strongly encourages proposals with a translational focus, or which are otherwise poised to accelerate the development of new stem cell-based therapies or cures. However, proposals at all stages of development are welcome. The HSCI intends to award up to five grants in response to this call for proposals, contingent upon the number and quality of the proposals received, as well as the availability of HSCI funds.... Read more about Call for Proposals: 2021 Fall HSCI Collaborative Seed Grants

HSCI co-director leads multi-institutional center to advance type 1 diabetes research

February 23, 2021

The JDRF Center of Excellence in New England will accelerate beta cell replacement therapy

Harvard Stem Cell Institute (HSCI) co-director Douglas Melton, Ph.D., will lead a new multi-institutional center funded by JDRF to advance type 1 diabetes research. The JDRF Center of Excellence in New England will focus on the transplantation of beta cells, the insulin-producing cells of the pancreas that are attacked by the immune system during type 1 diabetes.

The center is also led by JDRF scientific staff leader Esther Latres, Ph.D. Other collaborators include...

Read more about HSCI co-director leads multi-institutional center to advance type 1 diabetes research